BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Peninsula Pharmaceuticals, Inc. 

1701 Harbor Bay Parkway

Alameda  California  94502  U.S.A.
Phone: 510-747-3900 Fax:


SEARCH JOBS


Industry
Pharmaceutical






 Company News
East Bay Biotechs Hit Sales Block 1/3/2006 11:44:06 AM    More...
The Day In Review: Acquisitions Help Biotech 10/19/2005 5:13:13 PM    More...
Johnson & Johnson (JNJ) Announces Agreement; Ortho-McNeil Pharmaceutical, Inc. A Subsidiary Of Johnson & Johnson To Acquire Peninsula Pharmaceuticals, Inc.; $245 Million In Cash 10/19/2005 5:13:08 PM    More...
Peninsula Pharmaceuticals, Inc. Enters Into Discussions To Be Acquired; Delayed The Pricing Of Its Initial Public Offering 10/19/2005 5:12:40 PM    More...
Peninsula Pharmaceuticals, Inc. Announces Abstracts To Be Presented At The 44th Annual Interscience Conference On Antimicrobial Agents And Chemotherapy 10/19/2005 5:11:59 PM    More...
FDA Grants Peninsula Pharmaceuticals, Inc. Fast Track Designation For Doripenem 10/19/2005 5:11:57 PM    More...
Peninsula Pharmaceuticals, Inc. Completes Phase 1 Clinical Trial For PPI-0903 - A Novel Cephalosporin With In-vitro Activity Against Resistant Gram-positive Bacteria 10/19/2005 5:11:46 PM    More...
Peninsula Pharmaceuticals, Inc. Commences Phase I Clinical Trial For PPI-0903 10/19/2005 5:11:27 PM    More...
Peninsula Pharmaceuticals, Inc. Appoints Keith Katkin As Vice President Of Commercial Development 10/19/2005 5:11:17 PM    More...
Peninsula Pharmaceuticals, Inc. Elects David H. MacCallum To Its Board Of Directors 10/19/2005 5:11:06 PM    More...
123

//-->